Given the essential role of this pathway in HER2+ BC survival and proliferation, we hypothesized that SALL4 might play an important role in regulating cell proliferation and partially impeding trastuzumab resistance through the PI3K/AKT pathway. Here, ERBB2 is linked to breast cancer.